期刊文献+

罗氟司特对变应性鼻炎小鼠Th17细胞因子IL-17表达的作用研究 被引量:3

Effect of roflumilast on intracellular expression of Th17 cytokine interleukin17in murine model of allergic rhinitis
原文传递
导出
摘要 目的:探讨罗氟司特对变应性鼻炎小鼠鼻组织中Th17细胞因子IL-17的作用与其机制。方法:6~8周BALB/C雌性小鼠36只随机分成模型组、治疗组、对照组,每组12只。利用卵清蛋白(ovalbumin,OVA)致敏模型组和治疗组小鼠建立变应性鼻炎模型,造模成功后模型组继续以OVA滴鼻,而治疗组在滴鼻前30min给予罗氟司特灌胃干预。对照组均以生理盐水代替。取鼻腔固定脱钙HE染色观察其病理变化,取鼻黏膜分别提取孤独核受体(retinoid-related orphan receptor, ROR)γt、IL-17及其RNA行western blot和RT-PCR,检测RORγt与IL-17蛋白和RNA水平的表达变化。结果:治疗组鼻部炎症浸润稍减轻,RORγt、IL-17表达相比模型组明显减轻,但仍高于对照组(P〈0.05)。结论:变应性鼻炎小鼠IL-17表达明显增高,说明IL-17对变应性鼻炎发病起着促进作用,同时发现罗氟司特能抑制鼻组织RORγt的表达,阻止Th17的分化,从而减少IL-17的分泌。 OBJECTIVE To study the effects of roflumilast on intracellular expression of Th17 cytokine interleukin 17 in mu- fine model of allergic rhinitis. METHODS 36 female BALB/C mice were divided into 3 groups: control group, allergic rhinitis (AR) group and treatment group. The allergic rhinitis models were induced by classical method with OVA. The treatment group was given with roflumilast. After last challenge, the pathological differences between the three groups were be surveyed. The levels of RORγt and IL-17 were measured by Western blot and reverse transcription-polymerase chain reaction(RT-PCR). RESULTS The expressions of RORγt and IL-17 in treatment group were significantly lower than those of allergic rhinitis group, but significant higher than those of control group(P〈0. 05). CONCLUSION The levels of IL-17 were highly increased in allergic rhinitis group, which might be associated with pathogenesis of allergic rhinitis. And it was also found that roflumilast could in- hibit the release of IL-17 probably by inhibiting RORγt expression and blocking Th17 differentiation in murine of allergic rhinitis.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2013年第24期2022-2026,共5页 Chinese Journal of Hospital Pharmacy
基金 国家自然科学基金资助(编号:81271061) 国家临床重点专科建设项目经费资助(卫办医政函[2012]649号)
关键词 变应性鼻炎 罗氟司特 RORyt TH17 IL-17 allergic rhinitis roflumilast RORγt Th17 IL-17
  • 相关文献

参考文献10

  • 1Korn T, Bettelli E, Oukka M, et al. IL-17 and Th17 Cells [J]. Annu Rev Immunol, 2009,27 : 485-517.
  • 2Herbert C, Hettiaratchi A, Webb DC, el. al. Suppression of cytokine expression by roflumilast and dexamethasone in a model ot" chronic asthma[J]. Clin Exp Allergy, 2008,38,847- 857.
  • 3Zhao Y, Yang J,Gao YD, et al. Thl7 immunity in patients with allergic asthma [J]. Int Arch Allergy Immunol, 2010,151 (4) :297-307.
  • 4Ciprandi G;,De Amici M,Murdaca G,et al. Serum interleukin- 17 levels are related to clinical severity in allergic rhinitis[J]. Allergy, 2009,64(9) : 1375-1378.
  • 5瞿申红,李敏,黄永坚,欧志英,林志斌,梁建平,路文盛.变应原和糖皮质激素对变应性鼻炎患者外周血Th17细胞及其转录因子RORγt的作用[J].中华耳鼻咽喉头颈外科杂志,2009,44(12):996-1000. 被引量:23
  • 6Bopp T, Radsak M, Schmitt E, et al. New strategies for the manipulation of adaptive immune response[J]. Cancer Immu- nol Immunother,2010,59(9) : 1443 -1448.
  • 7Van Schalkwyk E, Strydom K, Williams Z, et al. Roflumi last, an oral, oncedaily phosphodiesterase 4 inhibitor, attenu- ates allergen induced asthmatic reactions[J]. J Allergy Clin Immunol, 2005,116 (2): 292-298.
  • 8Bousquet J, Aubier M, Sastre J ,et al. Comparison of roflumi last, an oral anti-inflammatory, with beclomethasone dipropb onate in the treatment of persistent asthma[J]. Allergy,2006, 61(1):72- 78.
  • 9Mucha SM, de Tineo M, Naclerio RM, et al. Comparison of montelukast and pseudoephedrine in the treatment of allergicrhinitis[J]. Arch Otolaryngol Head Neck Surg, 2006, 132: 164-172.
  • 10Bopp T, Dehzad N, Reuter S, et al. Inhibition of cAMP deg-radation improves regulatory T Cell Mediated Suppression[J]. J lmmunol, 2009,182: 4017-4024.

二级参考文献9

  • 1顾之燕,董震.变应性鼻炎的诊治原则和推荐方案(2004年,兰州)[J].中华耳鼻咽喉头颈外科杂志,2005,40(3):166-167. 被引量:1712
  • 2Harrington LE, Hatton RD, Mangan PR, et al. Interleukin 17 producing CD4^+ effector T ceils develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol, 2005,6 : 1123- 1132.
  • 3Harrington LE, Mangan PR, Weaver CT. Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curt Opin Immunol, 2006, 18: 349-356.
  • 4Oboki K, Ohno T, Saito H, et al. Th17 and allergy. Allergol Int, 2008, 57 : 121-134.
  • 5Wang YH, Liu YJ. The IL-17 cytokine family and their role in allergic inflammation. Curr Opin Immunol, 2008, 20: 697-702.
  • 6Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor ROR gammat directs the differentiation program of proinflammatory IL-17^+ T helper cells. Cell, 2006, 126: 1121-1133.
  • 7Ivanov II, Zhou L, Littman DR. Transcriptional regulation of Th17 cell differentiation. Semin Immunol, 2007, 19: 409-417.
  • 8Sutton CE, Lalor SJ, Sweeney CM, et al. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity, 2009, 31 : 331-341.
  • 9Ogura H, Murakami M, Okuyama Y, et al. Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity, 2008, 29 : 628-636.

共引文献22

同被引文献49

引证文献3

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部